|
|
Biography |
|
|
Professor Dr. Ahmed Elzawawy, Professor of Clinical Oncology (Port Said, Egypt). International Positions: President of the International Campaign for Establishment And Development of Oncology Centers (ICEDOC) & ICEDOC's Experts in Cancer Without Borders, USA. WWW.ICEDOC.ORG.
Co-President of South and East Mediterranean College of Oncology SEMCO. www.semco-oncology.info. Member in the executive council of the African Organization for Research and Training in cancer (AORTIC) www.AORTIC.org. Locally in Egypt, at present; Chairman & Professor of Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Suez Canal University & Chairman of Al Soliman Radiation Oncology Department, Port Said, Egypt. Education: MD., November 1975: M.B. CH.B, Faculty of Medicine, Alexandria University, Egypt. In 1981, accomplishment of post graduates studies in Radiotherapy, Oncology; France. Membership of international societies: member in American Society of Clinical Oncology (ASCO), European society of Medical Oncology (ESMO), American Society of Breast Health. Peer review editorial activities:"World Journal of Surgical Oncology", USA & a reviewer in "Surgical Oncology " UK. Other international activities: a consultant in fields related to cancer around the world.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
|
|
|
|
Exploring scientific avenues to increase affordability of treatment for more millions of patients with cancer in the world. Future prospects of win-win approaches.
Exploring scientific avenues to increase affordability of treatment for more millions of patients with cancer in the world. Future prospects of win-win approaches.
By: Prof. Dr. Ahmed Elzawawy. Affiliations and contact : President of ICEDOC & ICEDOC’s Experts in Cancer without Borders (ICEDOC: International Campaign for Establishment and Development of Oncology Centres , Texas , USA), Co-President of SEMCO South and East Mediterranean College of Oncology and Chairman of Clinical Oncology dept. Suez Canal University, Egypt. e-mail worldcooperation@gmail.com & ahmedelzawawy@hotmail.com & Web www.icedoc.org
By the year 2020, there will around twenty million new cancer cases, 70% of them in countries with only 5% of total resources for cancer control. With the increasing costs of the novel drugs and radiotherapy of cancer, and with the increase of incidence of cancer, we assume that there would be increasing problems of affordability cancer treatment in the world particularly in developing Countries..The overall and disease-free survival rates, scores of quality of life, cost effectives and cost utility are not increasing in a measure commensurate with the increase of expenses of cancer treatment. Hence, there would more difficulties and challenges for patients and their families, governments, physicians, industrialists and economists. The win-win approach proposed by ICEDOC’s Experts in Cancer without Borders ( ICEDOC: is the International Campaign for Establishment and Development of Oncology Centers) started in December 2007 with preparatory communications, and publications. We explore the recent scientific approaches and potential prospects that could lead to lower costs of breast cancer drug and radiation treatment without significant evidence of compromising the overall outcome. We started with breast cancer treatment as a model that a model that could be extended to other cancers. We recommend to adopt win-win scenarios and to create a think tank to foster innovative scientific thoughts and strategies that would aim at designing cost-effective, accessible, and more affordable for more millions of patients with cancers in the world . All stakeholders – including pharmaceuticals and radiotherapy equipment companies are considered.. Despite of all challenges, it would be truly a “win-win” scenario in which no one would lose..Not only North-South initiatives and scientific collaboration are important, but also. South- South scientific cooperation is recommended. Exchange of experiences and respecting the realistic biological, human, social and economic conditions, cost -effectiveness, cost -utility and considering actual quality of life as end point adapted to each community are recommended.
|
|
|
|
|